harm
Curated coverage for harm with top developments, timeline context, and connected threads.
James Marsden's Career Revival Is One of Hollywood's Best Stories Right Now
James Marsden went from franchise player to Hollywood's most charming utility actor to a specific 2026 career moment that has critics reassessing his entire filmography. Here is the story.
Bulk Importer | Linked source
Dossier Timeline
9 updatesThe New Science of Gut Bacteria That Eat Your Medication
Gut bacteria can metabolise and inactivate your medications before they reach the bloodstream. New research shows this varies enormously between people and explains why drugs work differently for different people.
EuroBulletin24 Editorial Desk | Linked source
The Bio-Harmony Diet That Knows When You Should and Shouldn't Eat
The 2026 nutrition trend 'bio-harmony' aligns eating with circadian rhythms and metabolic markers. Here is the science behind time-restricted eating and which specific approaches have the best evidence.
EuroBulletin24 Editorial Desk | Linked source
Cell-Free Biomanufacturing Is About to Revolutionise How We Make Medicine
Cell-free protein production platforms can make vaccines and drugs without living organisms. Here is what this breakthrough means for vaccine manufacturing speed and cost.
EuroBulletin24 Editorial Desk | Linked source
How a One-Year-Old US-EU Trade Deal Is Already Being Tested to Breaking Point
The US-EU trade framework was negotiated to provide stability. Here is why, less than a year in, it is already being stress-tested by the IEEPA ruling, NATO threats, and pharmaceutical tariff signals.
EuroBulletin24 Editorial Desk | Linked source
The Pharmaceutical Cold War: India Is Europe's Drug Supply Lifeline — And It's Vulnerable
Europe gets 70-80% of its generic medicine from India. The US pharmaceutical tariff threat and India's own policy changes are creating supply chain risks that European health ministries are quietly worried about.
EuroBulletin24 Editorial Desk | Linked source
The Pharmaceutical Sector Is Terrified of Trump's 200% Drug Tariff — Here Is Why the Math Doesn't Work
A 200% pharmaceutical tariff would be economically catastrophic for American patients. Here is exactly why the supply chain cannot be reshored quickly enough to prevent it.
EuroBulletin24 Editorial Desk | Linked source
Why the Supreme Court Letting Conversion Therapy Bans Fall Is Specifically Bad for Teenagers
Conversion therapy bans for minors were struck down by the Supreme Court. Here is the specific evidence of harm it produces in adolescents and what happens to them now.
EuroBulletin24 Editorial Desk | Linked source
The Pharmaceutical Tariff Trump Is Planning Could Hit 200% — Here Is What It Would Do to Medicine Prices
The Trump administration has signaled pharmaceutical tariffs could reach 200% by mid-to-late 2026. Here is what would happen to the price of medicines for American patients and globally.
EuroBulletin24 Editorial Desk | Linked source
AI in Medicine Is No Longer Just Diagnosis — It's Designing Molecules That Have Never Existed
AI systems are now designing entirely new drug molecules that chemists have never imagined. Here is the state of AI-powered drug discovery and what it means for medicine.
EuroBulletin24 Editorial Desk | Linked source